Old Web
English
Sign In
Acemap
>
Paper
>
MA04.02 Neratinib ± Temsirolimus in HER2-Mutant Lung Cancers: An International, Randomized Phase II Study
MA04.02 Neratinib ± Temsirolimus in HER2-Mutant Lung Cancers: An International, Randomized Phase II Study
2017
Leena Gandhi
Benjamin Besse
Julien Mazieres
Saiama N. Waqar
Alexis Cortot
Fabrice Barlesi
Elisabeth Quoix
Gregory A. Otterson
David S. Ettinger
Leora Horn
Denis Moro-Sibilot
Mark A. Socinski
Kathryn A. Gold
Jhanelle E. Gray
Ana B. Oton
Rebecca S. Heist
Daniel B. Costa
Leanne Mcculloch
Judith D. Bebchuk
Richard Bryce
Mark G. Kris
Keywords:
General surgery
Cancer research
Phases of clinical research
Temsirolimus
Neratinib
Lung
Oncology
Mutant
Medicine
Internal medicine
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
24
Citations
NaN
KQI
[]